RETRACTED: Skin barrier impairment at birth predicts food allergy at 2 years of age - 06/04/16
Doi : 10.1016/j.jaci.2015.12.1312
Maeve M. Kelleher, MD a, Audrey Dunn-Galvin, PhD a, Claire Gray, RN a, Deirdre M. Murray, MD, PhD a, b, Mairead Kiely, PhD c, Louise Kenny, PhD d, W.H. Irwin McLean, PhD, FRS e, Alan D. Irvine, MD, PhD b, f, g, Jonathan O'B. Hourihane, DM a, b, ⁎ 
a Paediatrics and Child Health, University College Cork, Cork, Ireland
c Vitamin D Research Group, School of Food and Nutritional Sciences, University College Cork, Cork, Ireland
b National Children's Research Centre, Dublin, Ireland
d Irish Centre for Fetal and Neonatal Translational Research, University College Cork, and Cork University Maternity Hospital, Cork, Ireland
e Dermatology and Genetic Medicine, University of Dundee, Dundee, United Kingdom
f Paediatric Dermatology, Our Lady's Children's Hospital, Dublin, Ireland
g Clinical Medicine, Trinity College Dublin, Dublin, Ireland
∗Corresponding author: Jonathan O'B. Hourihane, DM, Department of Paediatrics & Child Health, Cork University Hospital, Wilton, Cork, Ireland.Department of Paediatrics & Child HealthCork University HospitalWiltonCorkIreland
| Supported by the Food Safety Agency, United Kingdom (TO7060), and in part by grants from the Wellcome Trust (090066/B/09/Z and 092530/Z/10/Z to A.D.I. and W.H.I.M.). The BASELINE cohort is supported by the National Children's Research Centre, Dublin, Ireland. The Centre for Dermatology and Genetic Medicine, University of Dundee, is supported a Wellcome Trust Strategic Award (098439/Z/12/Z to W.H.I.M.). |
|
| Disclosure of potential conflict of interest: M. M. Kelleher receives research support from the Food Standards Agency and National Children's Research Centre, Ireland. A. Dunn-Galvin receives research funding form the National Children's Research Centre, Crumlin, Dublin for establishment of the cohort; the Food Standard Agency; and iFAAM. C. Gray receives research support from the Food Standards Agency and National Children's Research Centre, Ireland; serves as a consultant for Aimmune Corporation, and has grants pending with Aimmune Corporation and DBV Technologies. D. M. Murray receives research support from the Food Standards Agency and National Children's Research Centre, Ireland. M. Kiely receives research funding form the National Children's Research Centre, Crumlin, Dublin, for establishment of the cohort; the Food Standard Agency; ODIN; and iFAAM. L. Kenny receives research support from the Food Standards Agency, National Children's Research Centre, Ireland; serves as a consultant for Aimmune; and received payments for lectures from Thermo Fisher. W. H. I. McLean receives research funding from the Wellcome Trust. A. D. Irvine receives research support from the Food Standards Agency and National Children's Research Centre, Ireland; serves as a consultant for Regeneron and Anacor; and receives payments for lectures from Novartis. J. O'B. Hourihane receives research support from the Food Standards Agency and National Children's Research Centre, Ireland; serves as a consultant for the Aimmune Corporation; has grants pending with Aimmune Corporation and DBV Technologies; and receives payments for lectures from Thermo Fisher. |
© 2016
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 137 - N° 4
P. 1111 - avril 2016 Retour au numéro
Article précédent
- A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy
- Robert A. Wood, Jennifer S. Kim, Robert Lindblad, Kari Nadeau, Alice K. Henning, Peter Dawson, Marshall Plaut, Hugh A. Sampson
- Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy
- Stacie M. Jones, A. Wesley Burks, Corinne Keet, Brian P. Vickery, Amy M. Scurlock, Robert A. Wood, Andrew H. Liu, Scott H. Sicherer, Alice K. Henning, Robert W. Lindblad, Peter Dawson, Cecilia Berin, David M. Fleischer, Donald Y.M. Leung, Marshall Plaut, Hugh A. Sampson, Consortium of Food Allergy Research (CoFAR)
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?